Vericel (VCEL) Income towards Parent Company (2010 - 2026)

Vericel (VCEL) reported Income towards Parent Company of -$6.8 million for Q1 2026, up 41.85% on a YoY basis from -$4.8 million in Q1 2025, and down 128.33% sequentially from $24.1 million in Q4 2025.

Vericel (VCEL) Income towards Parent Company (2010 - 2026) Analysis & Trends

Vericel (VCEL) has 17 years of Income towards Parent Company data on file, last reported at -$6.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company rose 41.85% year-over-year to -$6.8 million; the trailing twelve-month figure through Mar 2026 stood at $20.9 million (up 946.8% YoY), and the FY2025 full-year result was $16.5 million, up 59.41% from the prior year.
  • Income towards Parent Company retreated to -$6.8 million in Q1 2026, from $24.1 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $24.1 million in Q4 2025 to a low of -$55.9 million in Q2 2023.
  • A 5-year average of -$3.1 million and a median of -$4.3 million in 2024 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company slumped 523.47% in 2023 and surged 614.21% in 2025, its largest moves.
  • Tracing VCEL's Income towards Parent Company over 5 years: stood at $5.9 million in 2022, then surged by 119.4% to $13.0 million in 2023, then soared by 52.44% to $19.8 million in 2024, then increased by 21.87% to $24.1 million in 2025, then tumbled by 128.33% to -$6.8 million in 2026.
  • Business Quant data shows VCEL's Income towards Parent Company at -$6.8 million in Q1 2026, $24.1 million in Q4 2025, and $4.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,071.81 Bn -
2 Nanobiotix 1,925.70 Bn 1,925.64 Bn -
3 Akari Therapeutics 1,062.88 Bn 1,062.88 Bn -
4 BeOne Medicines 469.09 Bn 464.29 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.09 Bn 115.84 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.32 Bn 61.57 Bn 3.31 Bn
7 Belite Bio 63.36 Bn 63.36 Bn -
8 Argenx Se 55.90 Bn 50.71 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.69 Bn 34.68 Bn 959.66 Mn
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.84 Mn
Dec 31, 2025 24.14 Mn
Sep 30, 2025 4.63 Mn
Jun 30, 2025 -997,000.00
Mar 31, 2025 -11.76 Mn
Dec 31, 2024 19.81 Mn
Sep 30, 2024 -901,000.00
Jun 30, 2024 -5.15 Mn
Mar 31, 2024 -4.33 Mn
Dec 31, 2023 12.99 Mn
Sep 30, 2023 -3.66 Mn
Jun 30, 2023 -55.88 Mn
Mar 31, 2023 -7.96 Mn
Dec 31, 2022 5.92 Mn
Sep 30, 2022 -6.58 Mn
Jun 30, 2022 -8.96 Mn
Mar 31, 2022 -7.09 Mn
Dec 31, 2021 4.54 Mn
Sep 30, 2021 -4.93 Mn
Jun 30, 2021 -3.79 Mn